Regeneron Pharmaceuticals
Regeneron is seeking a Senior Director to set strategy and drive execution for a portfolio of therapeutic programs and technologies, ensuring diagnostic strategies are integrated with clinical development and regulatory objectives. The role involves leading a team of diagnostic professionals, translating biomarker hypotheses into diagnostic plans, and overseeing assay selection, validation, and partner strategy. This position requires influencing cross-functional teams and external partners to ensure diagnostic and therapeutic success across the pipeline.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Director, Regulatory Affairs Companion Diagnostics
Revolution Medicines
Associate Director, Clinical Biomarker
lifelancer
Vice President, Translational Medicine
Annexon Biosciences
Associate Director, Translational Medicine
Atrium Therapeutics
Director Diagnostics
AstraZeneca
Director, Precision Medicine
Bristol Myers Squibb